RingCentral, Inc. (RNG) Stock Forecast
Data as of May 2, 2026Technology · Current price $45.35 (+12.82%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 13, 2026 | Joshua Reilly | Needham | $55.00 | +21.3% |
| Feb 23, 2026 | William Power | Robert W. Baird | $34.00 | -25.0% |
| Feb 20, 2026 | Siti Panigrahi | Mizuho Securities | $32.00 | -29.4% |
| Nov 4, 2025 | Elizabeth Porter | Morgan Stanley | $31.00 | -31.6% |
| Nov 4, 2025 | Joshua Reilly | Needham | $36.00 | -20.6% |
| Jan 7, 2025 | Michael Turrin | Wells Fargo | $30.00 | -33.8% |
| Jan 3, 2025 | Brian Peterson | Raymond James | $45.00 | -0.8% |
| Aug 5, 2024 | William Power | Robert W. Baird | $36.00 | -20.6% |
| Aug 2, 2024 | Catharine Trebnick | Rosenblatt Securities | $45.00 | -0.8% |
| Jul 10, 2024 | James Fish | Piper Sandler | $31.00 | -31.6% |
| May 9, 2024 | Matthew Niknam | Deutsche Bank | $42.00 | -7.4% |
| Feb 21, 2024 | Taz Koujalgi | Wedbush | $40.00 | -11.8% |
| Nov 7, 2023 | Siti Panigrahi | Mizuho Securities | $40.00 | -11.8% |
| Nov 7, 2023 | Catharine Trebnick | Rosenblatt Securities | $35.00 | -22.8% |
| Aug 8, 2023 | Ryan Koontz | Needham | $46.00 | +1.4% |
| May 26, 2023 | Ryan Koontz | Needham | $42.00 | -7.4% |
| Sep 23, 2022 | Fred Lee | Credit Suisse | $40.00 | -11.8% |
| Aug 16, 2022 | Michael Turrin | Wells Fargo | $100.00 | +120.5% |
| Jul 30, 2022 | Ryan MacWilliams | Barclays | $90.00 | +98.5% |
| May 21, 2022 | Michael Turrin | Wells Fargo | $115.00 | +153.6% |
Top Analysts Covering RNG
RNG vs Sector & Market
| Metric | RNG | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.56 | 2.34 | 2.41 |
| Analyst Count | 9 | 13 | 18 |
| Target Upside | -16.9% | +4072.8% | +14.9% |
| P/E Ratio | 94.48 | 27.82 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2.62B | $2.63B | $2.65B | 12 |
| 2027-03-31 | $667M | $671M | $674M | 4 |
| 2027-06-30 | $675M | $679M | $682M | 4 |
| 2027-09-30 | $689M | $693M | $696M | 5 |
| 2027-12-31 | $699M | $702M | $706M | 4 |
| 2028-03-31 | $695M | $699M | $702M | 3 |
| 2028-06-30 | $702M | $706M | $709M | 3 |
| 2028-09-30 | $714M | $718M | $722M | 5 |
| 2028-12-31 | $726M | $730M | $733M | 3 |
| 2029-12-31 | $3.04B | $3.06B | $3.08B | 7 |
| 2030-12-31 | $3.21B | $3.22B | $3.25B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $4.66 | $4.85 | $4.97 | 9 |
| 2027-03-31 | $1.28 | $1.28 | $1.29 | 4 |
| 2027-06-30 | $1.32 | $1.33 | $1.34 | 4 |
| 2027-09-30 | $1.38 | $1.39 | $1.39 | 4 |
| 2027-12-31 | $1.40 | $1.41 | $1.41 | 4 |
| 2028-03-31 | $1.41 | $1.42 | $1.43 | 5 |
| 2028-06-30 | $1.47 | $1.48 | $1.49 | 5 |
| 2028-09-30 | $1.53 | $1.54 | $1.55 | 5 |
| 2028-12-31 | $1.56 | $1.57 | $1.58 | 5 |
| 2029-12-31 | $6.99 | $7.04 | $7.10 | 1 |
| 2030-12-31 | $7.65 | $7.70 | $7.77 | 1 |
Frequently Asked Questions
What is the analyst consensus for RNG?
The consensus among 9 analysts covering RingCentral, Inc. (RNG) is Hold with an average price target of $37.67.
What is the highest price target for RNG?
The highest price target for RNG is $300.00, set by Ryan MacWilliams at Barclays on 2022-01-24.
What is the lowest price target for RNG?
The lowest price target for RNG is $30.00, set by Michael Turrin at Wells Fargo on 2025-01-07.
How many analysts cover RNG?
9 analysts have issued ratings for RingCentral, Inc. in the past 12 months.
Is RNG a buy or sell right now?
Based on 9 analyst ratings, RNG has a consensus rating of Hold (2.56/5) with a -16.9% upside to the consensus target of $37.67.
What are the earnings estimates for RNG?
Analysts estimate RNG will report EPS of $4.85 for the period ending 2026-12-31, with revenue estimated at $2.63B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.